fluphenazine has been researched along with procyclidine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (82.35) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gründig, E; Weiss, J | 1 |
| Mindham, RH | 1 |
| Annable, L; Chouinard, G; Nestoros, JN; Ross-Chouinard, A | 1 |
| Annable, L; Chouinard, G; Kropsky, ML; Ross-Chouinard, A | 1 |
| Bradley, R; Lamb, P; Mindham, RH | 1 |
| Varma, R | 1 |
| Checkley, S; Crammer, JL; Cutting, JC; Edwards, JG; Lader, MH; Murray, RM; Roberts, JE | 1 |
| Dinan, TG | 1 |
| Martin, DT; Swash, M | 1 |
| Holden, JM; Itil, TM; Keskiner, A; Patterson, CD | 1 |
| Bucci, L | 1 |
| Kline, NS | 1 |
| Han, H; Hsu, W; Itil, T; Keskiner, A; Ulett, G | 1 |
| Lopes, WP; Silverman, M | 1 |
| Adlersberg, S; Averbuch, E; Gonen, N; Mester, R; Spivak, B; Weizman, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
1 review(s) available for fluphenazine and procyclidine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 trial(s) available for fluphenazine and procyclidine
| Article | Year |
|---|---|
Assessment of drugs in schizophrenia. Asessment of drug-induced extrapyramidal reactions and of drugs given for their control.
Topics: Amantadine; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Drug Evaluation; Fluphenazine; Humans; Orphenadrine; Parkinson Disease, Secondary; Piribedil; Procyclidine | 1976 |
Ethopropazine and benztropine in neuroleptic-induced parkinsonism.
Topics: Adult; Benztropine; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Phenothiazines; Procyclidine; Schizophrenia; Tropanes | 1979 |
A comparison of piribedil, procyclidine and placebo in the control of phenothiazine-induced parkinsonism.
Topics: Chronic Disease; Clinical Trials as Topic; Fluphenazine; Humans; Parkinson Disease; Parkinson Disease, Secondary; Piperazines; Piribedil; Placebos; Procyclidine; Pyrrolidines; Schizophrenia | 1977 |
Comparison of phenothiazine and nonphenothiazine neuroleptics according to psychopathology, side effects and computerized EEG.
Topics: Alpha Rhythm; Chronic Disease; Clinical Trials as Topic; Computers; Electroencephalography; Female; Fluphenazine; Haloperidol; Humans; Male; Parkinson Disease; Parkinson Disease, Secondary; Placebos; Procyclidine; Psychiatric Status Rating Scales; Sleep; Thiothixene; Time Factors | 1974 |
EEG changes after fluphenazine enanthate and decanoate based on analog power spectra and digital computer period analysis.
Topics: Adult; Brain; Computers; Delayed-Action Preparations; Electroencephalography; Female; Fluphenazine; Humans; Injections, Intramuscular; Male; Methods; Middle Aged; Placebos; Procyclidine; Schizophrenia; Time Factors | 1971 |
11 other study(ies) available for fluphenazine and procyclidine
| Article | Year |
|---|---|
[The influence of neuroleptic drugs on urinary excretion of non-protein nitrogen (author's transl)].
Topics: Amino Acids; Clopenthixol; Clozapine; Creatinine; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Humans; Hydrogen-Ion Concentration; Ion Exchange Resins; Nitrogen; Procyclidine; Schizophrenia; Thioridazine; Tranquilizing Agents; Urea | 1976 |
Factors related to tardive dyskinesia.
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Fluphenazine; Follow-Up Studies; Hospitals, Psychiatric; Humans; Long-Term Care; Male; Middle Aged; Parkinson Disease, Secondary; Procyclidine; Schizophrenia | 1979 |
Simultaneous gas chromatographic determination of diphenylhydantoin, carbamazepin (Tegretol), phenobarbital and primidone in presence of Kemadrin (procyclidine) and Prolixin (fluphenazine) in plasma of psychiatric patients.
Topics: Anticonvulsants; Carbamazepine; Chromatography, Gas; Fluphenazine; Humans; Mental Disorders; Methods; Phenobarbital; Phenytoin; Primidone; Procyclidine; Pyrrolidines | 1978 |
A case of resistant schizophrenia.
Topics: Adult; Antipsychotic Agents; Drug Resistance; Fluphenazine; Humans; Male; Patient Readmission; Procyclidine; Schizophrenia, Paranoid | 1986 |
Neuroleptic effects on platelet aggregation: a study in normal volunteers and schizophrenics.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Haloperidol; Humans; Male; Platelet Aggregation; Procyclidine; Schizophrenia; Sulpiride; Trifluoperazine | 1987 |
Muscle pathology in the neuroleptic malignant syndrome.
Topics: Adult; Fluphenazine; Humans; Male; Muscles; Neuroleptic Malignant Syndrome; Procyclidine; Psychotic Disorders | 1987 |
Combined intramuscular administration of depot fluphenazine and benztropinemesylate in chronic schizophrenic patients.
Topics: 1-Propanol; Adult; Fluphenazine; Humans; Injections, Intramuscular; Male; Movement Disorders; Parasympatholytics; Procyclidine; Pyrrolidines; Schizophrenia | 1971 |
Greater than recommended drug dosages--some effects.
Topics: Adult; Extrapyramidal Tracts; Female; Fluphenazine; Humans; Male; Movement Disorders; Procyclidine; Schizophrenia; Trihexyphenidyl | 1970 |
Fluphenazine enanthate in the maintenance treatment of schizophrenia.
Topics: Fluphenazine; Humans; Orphenadrine; Procyclidine; Schizophrenia | 1968 |
Neuroleptic malignant syndrome associated with abrupt withdrawal of anticholinergic agents.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Fluphenazine; Humans; Male; Muscarinic Antagonists; Neuroleptic Malignant Syndrome; Penfluridol; Procyclidine; Schizophrenia; Substance Withdrawal Syndrome; Trihexyphenidyl | 1996 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |